BlackRock
CELU icon

BlackRock’s Celularity CELU Stock Holding History

BlackRock’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.7K Sell
76,359
-51,142
-40% -$49.1K ﹤0.01% 5202
2026
Q1 		$170K Buy
127,501
+12,646
+11% +$16K ﹤0.01% 4817
2025
Q4 		$127K Buy
114,855
+11,022
+11% +$19.8K ﹤0.01% 4838
2025
Q3 		$215K Buy
103,833
+768
+0.7% +$2.15K ﹤0.01% 4668
2025
Q2 		$202K Buy
103,065
+1,885
+2% +$3.43K ﹤0.01% 4671
2025
Q1 		$175K Sell
101,180
-471
-0.5% -$892 ﹤0.01% 4635
2024
Q4 		$211K Sell
101,651
-1,681
-2% -$4.01K ﹤0.01% 4608
2024
Q3 		$307K Buy
103,332
+12,584
+14% +$37.1K ﹤0.01% 4433
2024
Q2 		$284K Buy
90,748
+14,389
+19% +$49.9K ﹤0.01% 4478
2024
Q1 		$399K Sell
76,359
-782
-1% -$3.21K ﹤0.01% 4434
2023
Q4 		$191K Hold
77,141
– – ﹤0.01% 4651
2023
Q3 		$171K Hold
77,141
– – ﹤0.01% 4723
2023
Q2 		$411K Sell
77,141
-260,089
-77% -$1.67M ﹤0.01% 4536
2023
Q1 		$2.09M Sell
337,230
-23,643
-7% -$190K ﹤0.01% 4041
2022
Q4 		$4.66M Buy
360,873
+13,760
+4% +$254K ﹤0.01% 3754
2022
Q3 		$8.02M Buy
347,113
+268,626
+342% +$8.15M ﹤0.01% 3539
2022
Q2 		$2.67M Buy
78,487
+75,956
+3,001% +$6.17M ﹤0.01% 4116
2022
Q1 		$221K Hold
2,531
– – ﹤0.01% 5087
2021
Q4 		$130K Hold
2,531
– – ﹤0.01% 5204
2021
Q3 		$179K Buy
+2,531
New +$204K ﹤0.01% 5008

Other funds holding CELU

CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

BlackRock's CELU Position: Q2 2026 in Review

BlackRock reduced its Celularity (CELU) stake by 40% in Q2 2026, selling an estimated $49.1K and leaving 76,359 shares worth $45.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5202.

BlackRock first reported a position in CELU in Q3 2021 and has held it in 20 quarters since. The position peaked at $8.02M in Q3 2022. 39 funds tracked by Wall St. Rank hold CELU as of Q2 2026.

  • BlackRock held 76,359 shares of Celularity worth $45.7K as of Q2 2026.
  • BlackRock sold 51,142 Celularity shares in Q2 2026, an estimated $49.1K.
  • Celularity made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5202 holding.
  • BlackRock first reported a position in Celularity in Q3 2021 and has held it in 20 quarters since.
  • BlackRock's Celularity position peaked at $8.02M in Q3 2022.
  • 39 funds tracked by Wall St. Rank held Celularity as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.